Breast Cancer Clinical Trials in Guangzhou, Guangdong
31 recruitingGuangzhou, Guangdong, China
Showing 1–20 of 31 trials
Recruiting
Phase 1
An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors
Breast CancerAdvanced Solid Tumor
BeOne Medicines86 enrolled10 locationsNCT07222267
Recruiting
Phase 1
A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
Breast CancerGastric CancerOvarian Cancer+1 more
BeiGene258 enrolled24 locationsNCT06257264
Recruiting
Phase 3
Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease
Breast Cancer
Pfizer1,020 enrolled518 locationsNCT06760637
Recruiting
Not Applicable
Acupuncture and Compression for the Prevention of CIPN in Breast Cancer Patients
Breast CancerChemotherapy-induced Peripheral Neuropathy (CIPN)
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University384 enrolled1 locationNCT07377279
Recruiting
Phase 3
Study of Antivascular Therapy Combined With Chemotherapy Versus Chemotherapy in Adjuvant Therapy of TNBC-BLIS Patients (BCTOP-T-A03)
Breast Cancer
Fudan University764 enrolled15 locationsNCT05909332
Recruiting
Not Applicable
A Retrospective Analysis of Robot-Assisted Versus Endoscopic Breast-Conserving Surgery for Breast Cancer
Breast CancerBreast Surgery
Sixth Affiliated Hospital, Sun Yat-sen University200 enrolled1 locationNCT07321145
Recruiting
Phase 1Phase 2
Study of ACE-86225106 to Treat Patients With Advanced Solid Tumors
Breast CancerOvarian CancerProstate Cancer+3 more
Acerand Therapeutics (Shanghai) Limited298 enrolled14 locationsNCT06380660
Recruiting
Phase 3
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Breast Cancer
Pfizer400 enrolled153 locationsNCT07062965
Recruiting
Phase 2
A Study of YL202 in Selected Patients With Advanced Solid Tumors
Breast CancerNSCLCHNSCC+1 more
MediLink Therapeutics (Suzhou) Co., Ltd.200 enrolled82 locationsNCT06107686
Recruiting
Distribution of the Homologous Recombination-related (HRR) Genesmutationsand HRD in Breast Cancer
Breast CancerHER2-low Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University255 enrolled1 locationNCT05466786
Recruiting
Phase 1
A Study of BL-B01D1 in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors
Breast CancerSolid Tumor
Sichuan Baili Pharmaceutical Co., Ltd.36 enrolled2 locationsNCT05470348
Recruiting
Regional Radiotherapy Omission in Low-Risk Node Positive Breast Cancer
Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University635 enrolled1 locationNCT07179744
Recruiting
Not Applicable
RecurIndex Guided Avoidance of Regional Nodal Irradiation for Node Positive Breast Cancer
Breast CancerRadiation
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University540 enrolled1 locationNCT04069884
Recruiting
Phase 1Phase 2
A Study of YL202 in Combination With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors
Breast CancerAdvanced Solid Tumors
MediLink Therapeutics (Suzhou) Co., Ltd.414 enrolled20 locationsNCT07169994
Recruiting
Phase 3
Study to Evaluate Efficacy & Safety of Afuresertib Plus Fulvestrant in Patients With Locally Advanced or Metastatic HR+/HER2- Breast Cancer
Breast Cancer
Laekna Limited256 enrolled55 locationsNCT04851613
Recruiting
Phase 3
JSKN003 Versus Treatment Of Physician'S Choice For HER2-low, Unresectable and/or Metastatic Breast Cancer Subjects
Breast Cancer
Jiangsu Alphamab Biopharmaceuticals Co., Ltd400 enrolled87 locationsNCT06079983
Recruiting
Phase 3
Modulating the Skin Microbiome to Prevent Radiation Dermatitis in Breast Cancer
Breast CancerSkin MicrobiomeRadiation Dermatitis
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University326 enrolled1 locationNCT07066280
Recruiting
Phase 2
Arsenous Acid for Refractory Triple-Negative Breast Cancer
Breast Cancer
Sun Yat-sen University12 enrolled1 locationNCT06678048
Recruiting
Phase 2
Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer
Breast Cancer
Sun Yat-sen University192 enrolled5 locationsNCT06768931
Recruiting
Not Applicable
Correlation of Timing of Pegfilgrastim Administration and PIBP.
Breast CancerChemotherapyQuality of Life+3 more
Guangdong Provincial People's Hospital156 enrolled1 locationNCT05841186